Related Experiment Videos
Triptans versus analgesics.
1Department of Neurology, Rush Medical College, Chicago, IL 60062, USA.
Headache
|October 23, 2002
Summary
Most migraine patients prefer triptans over analgesics due to enhanced efficacy. Even with limitations, 70% of past triptan users continued their preference for these migraine treatments.
Area of Science:
- Neurology
- Pharmacology
- Clinical Medicine
Background:
- Migraine headaches are a common neurological condition.
- Treatment options include triptans and analgesics.
- Patient preference is a key factor in treatment adherence.
Purpose of the Study:
- To evaluate patient preferences for triptans versus analgesics in migraine management.
- To identify reasons behind patient choices between triptans and analgesics.
Main Methods:
- Retrospective survey of 663 migraine patients (ages 17-62).
- Data collected over a 3-month period in an office-based setting.
- Assessed preferences for triptans alone, triptans with analgesics, or analgesics alone.
Main Results:
- 70% of patients preferred triptans (alone or with analgesics).
- Increased efficacy was the primary reason for triptan preference (62%).
- 21% preferred analgesics alone, and 9% preferred neither.
Conclusions:
- Most migraine patients prefer triptans despite potential cost and limitations.
- Enhanced efficacy is the main driver for choosing triptans over analgesics.
- Patient-centered treatment decisions are crucial for effective migraine management.